InterpretOmics logo — company profile

InterpretOmics

Founded 2009 Angel Total: $1.60M Analytics, Biotechnology

General Information

Company Name InterpretOmics
Founded Year 2009
Founders / Decision Makers
Team member
Industries Analytics, Biotechnology
Funding Stage Angel
Social

Get notified when InterpretOmics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About InterpretOmics

InterpretOmics is an integrated genomics company specializing in genome-scale data analysis and interpretation products and services for healthcare, agriculture, and energy sectors. The company, founded in 2009, aims to derive significant biological insights from complex multi-omics data to aid in understanding human and crop diseases as well as drug responses. Utilizing public and proprietary databases, advanced computational infrastructure, and intricate algorithms, InterpretOmics analyzes data and delivers valuable interpretations. The company is notable for developing India's first enterprise-class genomics data analysis platform, iOMICS, addressing a wide range of challenges associated with Next Generation Sequencing data. It offers services encompassing the analysis and interpretation of whole genome, transcriptome, exome, metagenome, epigenome, and proteome data. Unlike other platforms focusing primarily on computational and software infrastructure for data handling, InterpretOmics places a strong emphasis on the interpretation and identification of rare data points (outliers) to transform raw genomic data into meaningful scientific insights. The last investment, totaling $1.60M, came from Amarante Shipping in an Angel Round investment at 13 August 2013. The company operates within the Analytics and Biotechnology industries.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round •••••• 1 •••• •••• 13 Aug 2013

InterpretOmics Alternatives & Competitors

InterpretOmics vs
Arpeggi Inc
Arpeggi Inc United States

Arpeggi is a life science company that provides complete end-to-end solutions for genome sequencing,...

Seed
11-50 employees
Biotechnology, Data Analytics
InterpretOmics vs
Cypher Genomics
Cypher Genomics United States

Unlocking the potential of human genome data through automated interpretation for clinical labs and...

Non Equity Assistance
2 employees
Analytics, Biotechnology
InterpretOmics vs

Providing advanced cancer genome data processing for research, biotech, and patient care sectors in...

Biotechnology, Health Care
Also compare with: InterpretOmics vs Phase Genomics Phase Genomics

FAQ About InterpretOmics

InterpretOmics InterpretOmics is an integrated genomics company specializing in genome-scale data analysis and interpretation products and services for healthcare, agriculture, and energy sectors. The company's mission is to derive significant biological insights from complex multi-omics data, aid...
InterpretOmics was founded in 2009.
InterpretOmics operates in the following industries: Analytics, Biotechnology.
InterpretOmics has completed 1 funding round, raising a total of $1.60M. The latest funding stage is Angel.
Top alternatives and competitors to InterpretOmics include Arpeggi Inc, Cypher Genomics, Five3 Genomics, Genome International , Nygen Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InterpretOmics and Arpeggi Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors InterpretOmics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes